This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Futscher, B. W. Articles by Erickson, L. C. Search for Related Content PubMed Articles by Futscher, B. W. Articles by Erickson, L. C.

Changes in c-myc and c-fos Expression in a Human Tumor Cell Line following Exposure to Bifunctional Alkylating Agents¹

Section of Hematology/Oncology, Departments of Medicine and Pharmacology, Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois 60153

This study was initiated to determine if DNA-damaging chemotherapeutic agents can suppress the expression of oncogenes. The effects of three structurally related bifunctional alkylating agents on the steady state mRNA levels of c-myc, c-fos, N-ras, and ß-actin in the human colon carcinoma cell line Colo320HSR were examined. Colo320HSR has an amplified c-myc oncogene, which is highly overexpressed, and is assumed to be one of the transforming genes of this cell line. Two concentrations of mechlorethamine, L-phenylalanine mustard, and 4-hydroperoxycyclophosphamide, which produced 1 or 3 log cell kills were used to examine the effects of drug exposure on the expression of specific genes. Steady state mRNA levels were measured by Northern blot analysis. Following a 1-h drug exposure, RNA was isolated from cells at 0, 6, 12, and 24 h following drug removal. The agents used produced changes in the expression of specific genes, and all three did so in a similar fashion. Immediately following drug removal, the steady state expression of c-myc in treated cells was increased 2- to 3-fold compared to control. At 6 and 12 h following drug removal, c-myc levels were depressed 2.5- to 5-fold. By 24 h, c-myc expression approached, but remained below, control levels. Immediately following drug removal, c-fos levels were increased 3- to 4-fold, and from 6 to 24 h following drug removal, c-fos levels gradually returned to, or fell below low basal levels. During the 24-h time course, drug treatment had little or no effect on the steady state levels of N-ras or ß-actin. These data support the hypothesis that alkylating agents may suppress the expression of specific transforming genes.

¹ This research was supported in part by a fellowship awarded to B. W. F. by the Arthur J. Schmitt Foundation, and NIH Grants R01 CA 45628 and R01 CA47929 awarded to L. C. E.

Received 2/15/89. Revised 9/ 7/89. Accepted 9/28/89.

This article has been cited by other articles:

				J. Yan and B. F. Hales Activator Protein-1 (AP-1) DNA Binding Activity Is Induced by Hydroxyurea in Organogenesis Stage Mouse Embryos Toxicol. Sci., June 1, 2005; 85(2): 1013 - 1023. [Abstract] [Full Text] [PDF]

				G. Los, K. Benbatoul, D. P. Gately, R. Barton, R. Christen, K. T. Robbins, D. Vicario, S. Kirmani, L. A. Orloff, R. Weisman, et al. Quantitation of the Change in GADD153 Messenger RNA Level as a Molecular Marker of Tumor Response in Head and Neck Cancer Clin. Cancer Res., July 1, 1999; 5(7): 1610 - 1618. [Abstract] [Full Text] [PDF]

				B. F. Hales Oxidative Stress Regulates the Expression and Activity of Transcription Factor Activator Protein-1 in Rat Conceptus J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 1085 - 1093. [Abstract] [Full Text]